|
Home Page About Your Prostate The Program
Discussion Group About The Book |
When Disease Recurs...Diagnosis and Treatment OptionsDr. Guy Bernstein, Urologist, Byrn Mawr Hospital Failed radiation therapy (RT) If disease is local, cryo could be considered. It looks good for lower grade disease. Incontinence could be a problem in up to 30%, although some cryo surgeons are having better results than that. RP could be considered in younger men, but the complications of rectal injury, incontinence, and urinary strictures are very common. Failed radical prostatectomy (RP) Decisions need to be based on two issues. Was the PSA ever undetectable following RP? Is the disease thought to be local or systemic? A work-up would normally include a bone scan; trans-rectal ultrasound (TRUS), with or without a biopsy; and ProstaScint. Although the latter is quite new, it appears to be much better in this setting than MRI or CT. If the ProstaScint is positive in the pelvis only, salvage RT will be more likely to be successful than if the ProstaScint is negative, or positive outside the pelvis. The best candidates for salvage RT had undetectable PSA post RP, a time to PSA or clinical failure of greater than 40 months, and tests indicating local disease. There is a 50% response rate in this setting (PSA going "toward" undetectable). Hormone therapy (HT) When used for recurrence, HT will always fail. However, if the initial response to HT was good, a second line of intervention using Ketoconazole or other agents will probably be good. One type of HT being tried for recurrence is high-dose Casodex at 150mg per day, with or without Proscar, but it is too early to comment on the results. Date: Tue, 30 Sep 1997 14:00:18 - 0400 Prostate Cancer Issues and Answers The following are some of my notes from the meeting. I've tried to accurately reflect what was said, but can't guarantee the reliability of these notes. The quotes are paraphrases, and ultimately, they are my interpretation of what I heard. I share these notes in the hope that someone may find something of value. Management of Possible Side Effect of Treatment:
|
| PSA<4 | PSA<1.5 | |
| Radiate Prostate only | 96 vs 85% | 76 vs 55% |
| Radiate Prostate and Pelvis | 82 vs 61% | 56 vs 33% |
Stamey's statement that 80% of men have a rising PSA 5 years after RT is a "lie." At Fox Chase, over 60% of men treated are disease- free.
The response rate rises rapidly when dose is increased from 65 Gy to 80 Gy, and treatment curves were shows to support this. Only 3DCRT can deliver the high doses needed to best response.
Late RTOG Grade 3 and 4 complications (the worst kind), are seen in 4.5 to 10% of cases in conventional treatment with doses of 65-70 Gy, and less than 1% of cases in 3DCRT with doses of 70-80 Gy.
In using 3DCRT for salvage therapy following RP, a target is defined by estimating where the prostate and seminal vesicles were located (via CT). The 3DCRT technique will reduce the exposure of normal tissues by 15-20% compared to conventionWhen Disease Recurs RT in this setting.
When Disease Recurs
Adding CHT to 3DCRT looks most promising in high grade tumors, In cases with Gleason 8, 9, and 10. There is a survival advantage at 5 years. In cases with PSA over 20, staged T3 or T4, adding CHT showed a survival advantage of 15-17% at 5 years.
In metastatic disease, patients going on CHT do better if the pretreatment testosterone level is high, rather than low.
Content
& copy © 1999,2000 The Prostate90
Education and Research Foundation
All Rights Reserved.
Last Updated : 6/17/2004